secombit: sequencing of targeted agents/immunomodulatory abs in metastatic brafv600-mutated melanoma
Published 4 years ago • 81 plays • Length 4:46Download video MP4
Download video MP3
Similar videos
-
1:48
secombit – determining the order of sequential therapies in metastatic melanoma with braf mutations
-
2:21
updates on the secombit trial
-
1:50
combination therapy for melanoma - open questions and the secombit trial
-
1:42
secombit: treatment sequencing in metastatic melanoma and incidence of brain metastasis
-
2:31
a subgroup analysis of the secombit trial
-
1:17
treatment selection for stage iii braf-mutant melanoma
-
5:39
melanoma musings: dr ascierto's trial updates from esmo
-
0:37
tils prolong pfs compared with pembrolizumab in advanced melanoma
-
0:47
bo-112: enhancing immune-checkpoint inhibition in solid tumors
-
1:12
current trials in the treatment of melanoma
-
1:30
treatment response assessment in melanoma and the challenge of pseudoprogression with immunotherapy
-
1:33
dr. schuchter: how can melanoma be detected
-
0:48
targeting c/ebpβ in melanoma
-
0:44
melanoma
-
2:39
brain metastasis: an important prognostic factor in melanoma
-
3:19
encorafenib in a combination regimen for braf melanoma
-
1:37
how to use the abcdes to detect melanoma
-
0:51
dr. schuchter reserves braf testing for advanced melanoma
-
5:52
unresectable melanoma—targeted or immunotherapy?